Endometriosis in Canada: It Is Time for Collaboration to Advance Patient-Oriented, Evidence-Based Policy, Care, and Research
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Journal of Obstetrics and Gynaecology Canada
- Vol. 43 (1) , 88-90
Abstract
No abstract availableKeywords
Funding Information
- Bayer Canada
- Bayer
- AbbVie
- Allergan
This publication has 6 references indexed in Scilit:
- Research priorities for endometriosis differ among patients, clinicians, and researchersAmerican Journal of Obstetrics and Gynecology, 2020
- Ignored Because It Is Benign – It Is Time to Treat Endometriosis as if It Were CancerJournal of Obstetrics and Gynaecology Canada, 2020
- A Practical Guide to the Clinical Evaluation of Endometriosis-Associated Pelvic PainJournal of Minimally Invasive Gynecology, 2020
- Top ten endometriosis research priorities in the UK and IrelandThe Lancet, 2017
- An Interdisciplinary Approach to Endometriosis-associated Persistent Pelvic PainJournal of Endometriosis and Pelvic Pain Disorders, 2017
- Economic Burden of Surgically Confirmed Endometriosis in CanadaJournal of Obstetrics and Gynaecology Canada, 2011